跳至主要内容
临床试验/CTRI/2022/01/039490
CTRI/2022/01/039490尚未招募3 期

A clinical study to assess the effect of Homoeopathic mother tincture Chelidonium majus in cases of Non Alcoholic Fatty Liver Disease with Dyslipidemia

Changlani sagar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with grade I, grade II and grade III nonalcoholic fatty liver disease will be
  • considered.
  • 2.Patients with known case of type 2 diabetes mellitus who are on conventional treatments
  • with HbA1c not more than 8%.
  • 3.Patients who have willingly join the study and signed the written informed consent

排除标准

  • 1.Patients who have alcoholic fatty liver disease
  • 2.Patient who has been diagnose with Viral hepatitis or auto immune hepatitis
  • 3.Patients who have any other metabolic disease like Hereditary hemochromatosis,
  • Alpha 1 antitrypsin deficiency , Wilson disease, Uncontrolled thyroid disease
  • 4.Patients who are diagnosed with liver disease due to any other etiology
  • 5.Patient with active cardio pulmonary manifestations.

研究者

发起方
Changlani sagar

相似试验